Research programme: biowarfare therapy - Large Scale Biology Corporation

Drug Profile

Research programme: biowarfare therapy - Large Scale Biology Corporation

Alternative Names: Acute Biowarfare Therapy Program; Biowarfare therapy research programme - Large Scale Biology Corporation

Latest Information Update: 07 Feb 2008

Price : $50

At a glance

  • Originator Large Scale Biology Corporation (CEASED)
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections; Viral infections

Most Recent Events

  • 23 Dec 2005 Large Scale Biology Corporation ceased operations
  • 30 Oct 2003 Preclinical trials in Bacterial infections in USA (unspecified route)
  • 30 Oct 2003 Preclinical trials in Viral infections in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top